Nyu Langone Medical Center · Class II · Cleared Jul 14, 2021
| K-number | K202304 |
| Device name | NYU Langone Genome PACT (Genome Profiling of Actionable Cancer Targets) |
| Applicant | Nyu Langone Medical Center |
| Product code | PZM |
| Device class | Class II |
| Decision date | Jul 14, 2021 |
| Decision | Substantially Equivalent |
| Regulation | 866.6080 |
AI extraction for this record is queued and will appear within 24 hours. View full FDA record →
View the full FDA submission: accessdata.fda.gov